跳至主要内容
临床试验/JPRN-jRCT2080223231
JPRN-jRCT2080223231已完成1 期

Clinical Pharmacology Study of CS-3150 Evaluation of the effect of repeated dose of itraconazole orally administered to healthy Japanese adult male on the pharmacokinetics of CS-3150

DAIICHI SANKYO Co.,Ltd.0 个研究点目标入组 20 人开始时间: 2016年6月6日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
20

研究概览

简要总结

When esaxerenone 2.5 mg was coadministered with itraconazole 200 mg, Cmax and AUC for esaxerenone increased by approximately 1.1 fold and 1.5-fold, respectively, compared to administration of esaxerenone alone. It was considered that there were no safety concerns when esaxerenone was administered concomitantly with itraconazole.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 45age old(—)
性别
Male

入选标准

  • 1)Japanese male
  • 2)Persons >= 20 years and =< 45 years of age at the time of informed consent
  • 3)Persons with a body mass index (BMI; calculated by body weight [kg]/height [m]2) of >= 18.5 kg/m2 and < 25.0 kg/m2 at the screening examination

排除标准

  • 1)Persons with hypersensitivity or idiosyncratic reactions to a drug, (such as penicillin allergy)
  • 2)Persons with drug or alcohol dependence

研究者

相似试验